Skip to content

Drug interactions

Glimepiride-pioglitazone + Simvastatin

Severity: Minor

Glimepiride-pioglitazone and Simvastatin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

The legacy concern is increased simvastatin myopathy via OATP1B1 inhibition by pioglitazone. Pioglitazone has not been shown to raise statin exposure meaningfully, and the combination is widely used. Pioglitazone may slightly lower simvastatin levels through CYP3A4 induction.

What this interaction means in plain words

Glimepiride-pioglitazone and Simvastatin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glimepiride-pioglitazone belongs to Endocrine; Simvastatin belongs to Cardiovascular.

Evidence level: Low

Why it happens

Theoretical transporter or CYP3A4 effects of pioglitazone; no established clinical effect.

What to do

No dose change needed; monitor lipid response and ask patients to report muscle symptoms.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Simvastatin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glimepiride-pioglitazone with Simvastatin?

MediHelp rates the interaction as minor. Glimepiride-pioglitazone and Simvastatin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. The legacy concern is increased simvastatin myopathy via OATP1B1 inhibition by pioglitazone. Pioglitazone has not been shown to raise statin exposure meaningfully, and the combination is widely used. Pioglitazone may slightly lower simvastatin levels through CYP3A4 induction.

How serious is the interaction between Glimepiride-pioglitazone and Simvastatin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change needed; monitor lipid response and ask patients to report muscle symptoms.

What other medicines interact with Glimepiride-pioglitazone?

MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in